- Home
- SXC vs FDMT Comparison
SXC vs FDMT Comparison
Compare SXC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXC | FDMT |
|---|---|---|
| Founded | 1960 | 2013 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.5M | 513.6M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SXC | FDMT |
|---|---|---|
| Price | $5.99 | $8.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $9.00 | ★ $32.40 |
| AVG Volume (30 Days) | ★ 1.9M | 674.7K |
| Earning Date | 05-20-2026 | 04-13-2026 |
| Dividend Yield | ★ 7.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,600,300,000.00 | $37,000.00 |
| Revenue This Year | N/A | $21,227.03 |
| Revenue Next Year | $4.74 | $161.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $2.24 |
| 52 Week High | $9.82 | $12.34 |
Technical Indicators
Market Signals| Indicator | SXC | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 42.07 |
| Support Level | $5.52 | $8.15 |
| Resistance Level | $6.97 | $8.80 |
| Average True Range (ATR) | 0.30 | 0.55 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 46.38 | 7.86 |
Price Performance
Historical ComparisonAbout SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.